Campral and Naproxen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campral (acamprosate calcium) and Naproxen (naproxen). Common drug interactions include chest pain among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Campral and Naproxen. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Campral?

Campral has active ingredients of acamprosate calcium. It is often used in alcoholism. eHealthMe is studying from 1,007 Campral users. Check the latest studies of Campral.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,032 Naproxen users. Check the latest studies of Naproxen.



On Jul, 13, 2026

11 people who take Campral and Naproxen together, and have interactions are studied.

Campral and Naproxen drug interactions.

What are the common drug interactions of Campral and Naproxen, by gender? *:

female:

  1. Chest pain
  2. Chronic kidney disease
  3. Disease recurrence
  4. Dyspnoea (difficult or laboured respiration)
  5. Facial palsy (paralysis of face nerve)
  6. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Herpes zoster oticus (viral infection of the inner, middle, and external ear caused by varicella-zoster virus (vzv))
  9. Infected cyst
  10. Injection site pain

male:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Oropharyngeal blistering (blister of oropharynx)
  3. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  4. Diarrhoea
  5. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)

What are the common drug interactions of Campral and Naproxen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Oropharyngeal blistering (blister of oropharynx)
  3. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  4. Chronic kidney disease
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Visual impairment

40-49:

  1. Arthralgia (joint pain)
  2. Carbuncle (a carbuncle is an abscess larger than a boil)
  3. Cellulitis (infection under the skin)
  4. Chest pain
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. Facial palsy (paralysis of face nerve)
  8. Herpes zoster oticus (viral infection of the inner, middle, and external ear caused by varicella-zoster virus (vzv))
  9. Infected cyst
  10. Intentional self-injury

50-59:

  1. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  2. Diarrhoea
  3. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)

60+:

  1. Diarrhoea
  2. Disease recurrence
  3. Injection site pain
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Procedural pain
  6. Pruritus (severe itching of the skin)
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Thoracic vertebral fracture

What are the existing conditions these people have? *

  1. Stress And Anxiety: 4 people, 36.36%
  2. Quit Smoking: 4 people, 36.36%
  3. Urinary Tract Infection: 3 people, 27.27%
  4. Asthma: 3 people, 27.27%
  5. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 27.27%
  6. Joint Pain: 3 people, 27.27%
  7. High Blood Pressure: 3 people, 27.27%
  8. High Blood Cholesterol: 3 people, 27.27%
  9. Bone Disorder: 3 people, 27.27%
  10. Depressed Mood: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Campral and Naproxen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Campral and Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Campral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Campral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acamprosate calcium and naproxen (the active ingredients of Campral and Naproxen, respectively), and Campral and Naproxen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: